DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zyprexa (Olanzapine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (128)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zyprexa (Olanzapine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 128   Next >>

Possible Zyprexa side effects in 62 year old male

Reported by a individual with unspecified qualification from United States on 2012-08-22

Patient: 62 year old male, weighing 93.4 kg (205.6 pounds)

Reactions: Sedation, Fall, Somnolence, Asthenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa



Possible Zyprexa side effects in 17 year old male

Reported by a consumer/non-health professional from Venezuela on 2012-08-13

Patient: 17 year old male

Reactions: Agitation, Mydriasis, Intentional Overdose, Suicide Attempt, Depressed Level of Consciousness, Unevaluable Event

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa
    Dosage: 110 mg, unk
    Start date: 2012-07-17
    End date: 2012-07-17

Zyprexa
    Dosage: 10 mg, qd
    Administration route: Oral
    Start date: 2011-11-01
    End date: 2012-07-17



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from France on 2012-08-03

Patient: male

Reactions: Mydriasis, Respiratory Disorder, Central Nervous System Lesion, Ischaemic Stroke, Cerebellar Syndrome, Cerebellar Haematoma, Bladder Dilatation, Pulmonary Congestion, Depression, Hypertension, Deep Vein Thrombosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Risperdal; Polyethylene Glycol; Tercian; Loxapine HCL; Risperdal Consta; Escitalopram; Risperdal; Lepticur; Imovane



Possible Zyprexa side effects in 19 year old male

Reported by a physician from Switzerland on 2012-07-31

Patient: 19 year old male

Reactions: Agitation, Yawning, Hallucination, Auditory, Dementia, Tachycardia, Hypotension, Opisthotonus, Encephalopathy, Abnormal Behaviour, Speech Disorder, Bradycardia, Gait Disturbance, Altered State of Consciousness, Hypertension, Acute Disseminated Encephalomyelitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Haloperidol; Haloperidol



Possible Zyprexa side effects in male

Reported by a physician from Japan on 2012-07-26

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Off Label Use, Psychomotor Hyperactivity, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Diazepam; Depakene; Levetiracetam; Silece; Levetiracetam; Tegretol; Lendormin; Valproate Sodium



Possible Zyprexa side effects in male

Reported by a physician from France on 2012-07-26

Patient: male

Reactions: Agranulocytosis, Transplant Rejection, Toxicity To Various Agents, Pericardial Effusion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Cellcept; Perindopril Erbumine



Possible Zyprexa side effects in 56 year old female

Reported by a consumer/non-health professional from United States on 2012-07-24

Patient: 56 year old female, weighing 81.6 kg (179.6 pounds)

Reactions: Back Pain, Neck Pain, Renal Transplant, Urinary Tract Infection, Blood Potassium Increased, Type 1 Diabetes Mellitus

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Effexor XR
    Dosage: 125 mg 1 daily oral
    Administration route: Oral
    Indication: Depression
    Start date: 2002-01-01
    End date: 2012-02-01

Latuda

Seroquel

Zyprexa
    Dosage: 15 mg 1 day oral
    Administration route: Oral
    Indication: Schizoaffective Disorder



Possible Zyprexa side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-23

Patient: male

Reactions: Ischaemic Stroke, Psychiatric Decompensation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Loxapine HCL
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-12-02
    End date: 2010-12-08

Risperdal
    Administration route: Oral
    Start date: 2010-12-02
    End date: 2010-12-08

Risperdal
    Administration route: Oral
    Start date: 2010-11-23

Risperdal
    Administration route: Oral

Risperdal
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-12-16

Risperdal Consta
    Indication: Persecutory Delusion
    Start date: 2010-12-03
    End date: 2010-12-03

Tercian
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-07-09
    End date: 2010-12-02

Zyprexa
    Administration route: Oral
    Indication: Persecutory Delusion
    Start date: 2010-07-09
    End date: 2010-11-23

Other drugs received by patient: Imovane; Lepticur; Lepticur; Polyethylene Glycol; Escitalopram



Possible Zyprexa side effects in

Reported by a physician from Australia on 2012-07-19

Patient:

Reactions: Electrocardiogram QT Prolonged, Cardiac Murmur, Foetal Exposure During Pregnancy, Bradycardia Neonatal, Foetal Distress Syndrome, Amniotic Fluid Volume Decreased, Type 1 Diabetes Mellitus, Hypothermia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa
    Dosage: 10 mg, each evening
    Start date: 2010-06-01

Zyprexa
    Dosage: 10 mg, each evening
    Start date: 2010-06-01



Possible Zyprexa side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-19

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Zyprexa side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Zyprexa side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-11

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Alprazolam; Rinderon-V



Possible Zyprexa side effects in 34 year old male

Reported by a physician from Japan on 2012-07-10

Patient: 34 year old male

Reactions: Agitation, Blood Creatine Phosphokinase Increased, Procalcitonin Increased, Blood Urea Increased, Body Temperature Increased, Delirium, Convulsion, Critical Illness Polyneuropathy, C-Reactive Protein Increased, Oliguria, Heart Rate Increased, Blood Pressure Decreased, Enterocolitis, Blood Creatinine Increased, White Blood Cell Count Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Lithium Carbonate; Valproate Sodium; Brotizolam; Quetiapine; Flunitrazepam



Possible Zyprexa side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa + Levodopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V; Alprazolam



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from Japan on 2012-06-29

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: Off Label Use, Psychomotor Hyperactivity, Dehydration, Neuroleptic Malignant Syndrome

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Diazepam; Valproate Sodium; Levetiracetam; Silece; Depakene; Levetiracetam; Tegretol; Lendormin



Possible Zyprexa side effects in 34 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-28

Patient: 34 year old male

Reactions: Blood Creatine Phosphokinase Increased, Disseminated Intravascular Coagulation, Diabetic Ketoacidosis, Acute Respiratory Failure, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa



Possible Zyprexa side effects in male

Reported by a physician from France on 2012-06-27

Patient: male

Reactions: Agranulocytosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cellcept
    Administration route: Oral
    Indication: Heart Transplant
    End date: 2012-05-22

Perindopril Erbumine
    Indication: Hypertension
    End date: 2012-05-22

Zyprexa
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-02-15
    End date: 2012-05-21

Other drugs received by patient: Solu-Medrol; Prograf; Neoral



Possible Zyprexa side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Zyprexa side effects in 34 year old male

Reported by a physician from Japan on 2012-06-20

Patient: 34 year old male

Reactions: Agitation, Procalcitonin Increased, Blood Creatine Phosphokinase Increased, Blood Urea Increased, Body Temperature Increased, Delirium, Convulsion, Critical Illness Polyneuropathy, C-Reactive Protein Increased, Oliguria, Heart Rate Increased, Blood Pressure Decreased, Blood Creatinine Increased, Enterocolitis, White Blood Cell Count Increased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Brotizolam; Lithium Carbonate; Flunitrazepam; Quetiapine; Valproate Sodium



Possible Zyprexa side effects in male

Reported by a physician from France on 2012-06-19

Patient: male

Reactions: Overdose, Agranulocytosis, Heart Transplant Rejection, Toxicity To Various Agents

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cellcept
    Administration route: Oral
    Indication: Heart Transplant
    End date: 2012-05-22

Perindopril Erbumine
    Indication: Hypertension
    End date: 2012-05-22

Zyprexa
    Administration route: Oral
    Indication: Psychotic Disorder
    Start date: 2012-02-15
    End date: 2012-05-21

Other drugs received by patient: Neoral; Prograf; Solu-Medrol



Possible Zyprexa side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-15

Patient: male, weighing 93.0 kg (204.6 pounds)

Reactions: Glucose Tolerance Impaired, Hepatic Steatosis

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Zyprexa



Possible Zyprexa side effects in 32 year old female

Reported by a consumer/non-health professional from Germany on 2012-06-12

Patient: 32 year old female

Reactions: Drug Level Above Therapeutic, Overdose, Suicide Attempt, Respiratory Depression, Suicidal Ideation, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Citalopram Hydrobromide



Possible Zyprexa side effects in 34 year old male

Reported by a consumer/non-health professional from Japan on 2012-06-07

Patient: 34 year old male

Reactions: Blood Creatine Phosphokinase Increased, Disseminated Intravascular Coagulation, Diabetic Ketoacidosis, Acute Respiratory Failure, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa



Possible Zyprexa side effects in female

Reported by a consumer/non-health professional from France on 2012-06-04

Patient: female

Reactions: Hepatitis B Surface Antibody Positive, Hepatic Steatosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Imovane; Citalopram Hydrobromide; Risperdal



Possible Zyprexa side effects in male

Reported by a physician from Japan on 2012-05-29

Patient: male, weighing 50.0 kg (110.0 pounds)

Reactions: Polydipsia, Carcinoembryonic Antigen Increased, Rectal Cancer, Platelet Count Decreased, Electrolyte Imbalance, Thirst, Urinary Retention, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Ferotym; Besacolin; Valproate Sodium; Flunitrazepam; Ubtec; Tamsulosin Hydrochloride; Cefazolin Sodium; Zolpidem; Mecobalamin; Gamofa; Magnesium Sulfate



Possible Zyprexa side effects in male

Reported by a physician from France on 2012-05-25

Patient: male, weighing 104.0 kg (228.8 pounds)

Reactions: Rhabdomyolysis, Coma, Renal Tubular Necrosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Lexomil; Amlodipine Besilate W / Olmesartan Medoxomil; Depakote; Naproxen; Colchicine



Possible Zyprexa side effects in female

Reported by a physician from Italy on 2012-05-18

Patient: female

Reactions: Incontinence, Rhabdomyolysis, Gastrooesophageal Reflux Disease, Fall, Haematemesis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Rosuvastatin
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2008-01-01
    End date: 2011-12-03

Zyprexa
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 1997-01-01
    End date: 2011-12-03

Other drugs received by patient: Ramipril; Lansoprazolo (Lansoprazole); Metoprololo (Metorprolol); Aspirin; Nitriglicerina (Nitroglycerin)



Possible Zyprexa side effects in male

Reported by a physician from France on 2012-05-17

Patient: male

Reactions: Liver Injury, Road Traffic Accident, Neuroleptic Malignant Syndrome, Leukocytosis, Shock, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Zyprexa

Other drugs received by patient: Stablon; Lepticur



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017